Tetra Bio-Pharma announced that they have completed preclinical trials on the experimental drug that ... [+] could be helpful for reducing inflammation, scarring and damage in the lungs. One company that specializes in cannabinoid based drugs, Tetra Bio-Pharma, even announced that they would be investigating a synthetic cannabinoid drug for Covid-19, called ARDS-003, in FDA clinical trials. While these preclinical results from Tetra Bio-Pharma don’t yet show that ARDS-003 will necessarily help with Covid-19, the synthetic cannabinoid was designed with that purpose in mind. In these preclinical studies, Tetra Bio-Pharma explored whether ARDS-003 showed promise for treating extreme lung inflammation and damage. In these studies, lung inflammation was intentionally induced in animals, and then they were treated with ARDS-003.

Source: Forbes October 21, 2020 19:41 UTC